Report date: Nov 6,2024
Conflict count: 361874
Publisher: Publishing House ABV Press
Title count: 1
Conflict count: 8


==========================================================

Created: 2015-08-12 13:44:14
ConfID: 4964571
CauseID: 1383164352
OtherID: 1383162876
JT: Advances in molecular oncology
MD: Vshivkoo,2,1,13,2015,The role of Ikaros transcriptional factor in normal hematopoiesis and leukemogenesis: biological and clinical aspects
DOI: 10.17650/2313-805X.2015.2.1.13-26(Journal) (4964571-N)
DOI: 10.17650/2313-805X.2015.2.1.013-026(Journal)
==========================================================

Created: 2015-08-12 13:44:14
ConfID: 4964570
CauseID: 1383164352
OtherID: 1383162876
JT: Advances in molecular oncology
MD: Malek,2,1,4,2015,MicroRNA: sex steroids, hormonal carcinogenesis, hormonal sensitivity of tumor tissue
DOI: 10.17650/2313-805X.2015.2.1.4-12(Journal) (4964570-N)
DOI: 10.17650/2313-805X.2015.2.1.004-012(Journal)
==========================================================

Created: 2015-08-12 13:44:14
ConfID: 4964575
CauseID: 1383164352
OtherID: 1383162876
JT: Advances in molecular oncology
MD: Lyubimova,2,1,61,2015,Biochemical markers of bone metastasis
DOI: 10.17650/2313-805X.2015.2.1.61-75(Journal) (4964575-N)
DOI: 10.17650/2313-805X.2015.2.1.061-075(Journal)
==========================================================

Created: 2015-08-12 13:44:14
ConfID: 4964574
CauseID: 1383164352
OtherID: 1383162876
JT: Advances in molecular oncology
MD: Delektorskaya,2,1,52,2015,Neuroendocrine tumors of the digestive system: pathologic and molecular characteristics
DOI: 10.17650/2313-805X.2015.2.1.52-60(Journal) (4964574-N)
DOI: 10.17650/2313-805X.2015.2.1.052-060(Journal)
==========================================================

Created: 2015-08-12 13:44:14
ConfID: 4964573
CauseID: 1383164352
OtherID: 1383162876
JT: Advances in molecular oncology
MD: Stavrovskaya,2,1,39,2015,News in the studies of multidrug resistance of breast cancer cells
DOI: 10.17650/2313-805X.2015.2.1.39-51(Journal) (4964573-N)
DOI: 10.17650/2313-805X.2015.2.1.039-051(Journal)
==========================================================

Created: 2015-08-12 13:44:14
ConfID: 4964572
CauseID: 1383164352
OtherID: 1383162876
JT: Advances in molecular oncology
MD: Fedyanin,2,1,27,2015,Перспективы терапевтического воздействия на сигнальный путь FGFR
DOI: 10.17650/2313-805X.2015.2.1.27-38(Journal) (4964572-N)
DOI: 10.17650/2313-805X.2015.2.1.027-038(Journal)
==========================================================

Created: 2015-08-12 13:44:14
ConfID: 4964577
CauseID: 1383164352
OtherID: 1383162876
JT: Advances in molecular oncology
MD: Strizhevskaya,2,1,82,2015,Biochemical criteria of toxicity of therapy with high doses of methotrexate in children with osteosarcoma
DOI: 10.17650/2313-805X.2015.2.1.82-89(Journal) (4964577-N)
DOI: 10.17650/2313-805X.2015.2.1.082-089(Journal)
==========================================================

Created: 2015-08-12 13:44:14
ConfID: 4964576
CauseID: 1383164352
OtherID: 1383162876
JT: Advances in molecular oncology
MD: Boichuk,2,1,76,2015,Imatinib enchances the sensitivity of gastrointestinal stromal tumors to topoisomerase II inhibitors
DOI: 10.17650/2313-805X.2015.2.1.76-81(Journal) (4964576-N)
DOI: 10.17650/2313-805X.2015.2.1.076-081(Journal)